In this webinar we discuss the best practices and hurdles to implement tangible medical affairs impact measurement.
This article explores key questions on how Medical Affairs teams manage patient engagement across different-sized companies who have variations in focus, resources, and scale.
In this webinar, we will discuss the regulatory bodies such as the Food and Drug Administration (FDA) and European Medicines Agency (EMA) are increasingly recognising the value of supplementing clinical trial data with real-world evidence to improve understanding of drug performance in the healthcare setting.
Getting the most impact from a publication requires being able to define who the audience is and how to reach them, across both journals and online channels, especially in complex/niche cases. In this podcast, we discuss the benefits of taking an analytical approach.
This webinar aims to help viewers articulate why it’s important to consider a patient community audience when planning scientific and data dissemination including incorporating their voice within it.
This advanced module to Patient Centricity will provide a solid overview of how the industry approaches compliance and governance in patient engagement. A suggested prerequisite to the course is the “Essential Concepts of Patient Centricity” eLearning module.
This webinar will focus on the role of Medical Affairs to lead patient engagement in clinical development.
Health literacy is experiencing new challenges, and Medical Affairs is uniquely positioned to lead and partner with others in this space to ensure coordination, credibility and impact.
MAPS speaks with Liz de Somer, CEO of Medicines Australia and Sharon Winton, CEO of Lymphoma Australia to explore patient engagement from the perspectives of industry and patient associations.
In this on-demand webinar, our experts provide guidance and potential solutions on addressing major barriers for patient centricity initiatives identified through their survey.